Qiming Wang

机构：Hunan Cancer Hospital, Henan Cancer Hospital, Nanjing Medical University · ORCID：0000-0003-3217-1077

发表论文 309 篇 · 总被引 9870 次 · h-index 41

代表论文

• CAMPASS: Benmelstobart in combination with anlotinib vs pembrolizumab in the first-line treatment of advanced non-small cell lung cancer (aNSCLC)—A randomized, single-blind, multicenter phase 3 study. (2025 · Journal of Clinical Oncology · 被引 8)
• Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study (2025 · The Lancet Oncology · 被引 6)
• Ribosomal protein RPL7A modulates lung adenocarcinoma progression via circRANBP17–UPF1-mediated SIRT6 degradation (2025 · Cellular & Molecular Biology Letters · 被引 5)
• Fibroblast-secreted ADAMTSL2 promotes cardiac repair after myocardial infarction by activating LRP6/β-catenin signaling (2025 · Cellular Signalling · 被引 5)
• HMGB2 Promotes Cardiomyocyte Proliferation and Heart Regeneration Through MTA2‐Driven Metabolic Reprogramming (2025 · Advanced Science · 被引 3)
• Vericiguat in patients with acute coronary syndrome and reduced ejection fraction: the EVE-ACSrEF study (2026 · BMC Cardiovascular Disorders · 被引 1)